Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Grace Therapeutics, Inc GRCE

Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aneurysmal subarachnoid hemorrhage (aSAH) patients to address significant unmet medical needs. GTX-104 provides a convenient IV delivery of nimodipine in the intensive care unit, eliminating the need for nasogastric tube administration in unconscious or dysphagic patients. Its other pipeline drug candidates include GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia and GTX-101, which is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.


NDAQ:GRCE - Post by User

Bullboard Posts
Comment by boozehound3on Jun 12, 2019 7:59pm
62 Views
Post# 29820489

RE:RE:RE:RE:RE:2 New Buyers released. Accumulating has began

RE:RE:RE:RE:RE:2 New Buyers released. Accumulating has began i told you  i got sucked into this bs stock          i don't want to hear your bs about 8.00.  you guys just put your head in the sand and don't want to hear facts about this thing.

if you want to give me a 1.40 for my shares you can have them



thero in his latest presentation talked about how there has been no product with both epa and dha that has worked          the dha is complex and stops absorbtion of the epa!

look it up         i am telling you i think this whole thing with fish oil is bs.  i don't think it acheived as large a reductiuon as they say. amarin may get away with it though.  it is one of those drugs that they can sell and if it works great but if it doesn't know one will know any different so they can keep selling it.   fda may want another trial
Bullboard Posts